Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 20 04:00PM ET
14.31
Dollar change
-0.10
Percentage change
-0.69
%
IndexRUT P/E- EPS (ttm)-2.80 Insider Own1.47% Shs Outstand88.79M Perf Week-4.22%
Market Cap1.27B Forward P/E24.22 EPS next Y0.59 Insider Trans-17.02% Shs Float87.50M Perf Month-18.51%
Income-226.71M PEG- EPS next Q-0.28 Inst Own112.64% Short Float14.29% Perf Quarter-31.30%
Sales273.53M P/S4.65 EPS this Y74.79% Inst Trans4.11% Short Ratio6.94 Perf Half Y-18.23%
Book/sh0.37 P/B38.71 EPS next Y157.43% ROA-37.27% Short Interest12.50M Perf Year95.23%
Cash/sh3.63 P/C3.94 EPS next 5Y- ROE-422.66% 52W Range6.80 - 25.29 Perf YTD-17.85%
Dividend Est.- P/FCF- EPS past 5Y-3.34% ROIC-63.14% 52W High-43.42% Beta0.74
Dividend TTM- Quick Ratio2.03 Sales past 5Y5.87% Gross Margin79.02% 52W Low110.44% ATR (14)0.85
Dividend Ex-Date- Current Ratio2.05 EPS Y/Y TTM44.52% Oper. Margin-82.29% RSI (14)38.47 Volatility2.82% 2.89%
Employees385 Debt/Eq12.20 Sales Y/Y TTM49.29% Profit Margin-82.88% Recom1.25 Target Price34.27
Option/ShortYes / Yes LT Debt/Eq9.94 EPS Q/Q73.55% Payout- Rel Volume0.74 Prev Close14.41
Sales Surprise-1.82% EPS Surprise17.11% Sales Q/Q97.54% EarningsMay 01 AMC Avg Volume1.80M Price14.31
SMA20-4.57% SMA50-15.03% SMA200-19.44% Trades Volume1,328,496 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Jun-11-25Resumed H.C. Wainwright Buy $30
Jun-11-25Reiterated Citigroup Buy $35 → $32
Jan-10-25Initiated Cantor Fitzgerald Overweight
Oct-21-24Upgrade Wells Fargo Equal Weight → Overweight $9 → $27
Oct-16-24Initiated Scotiabank Sector Outperform
Sep-09-24Upgrade Guggenheim Neutral → Buy $25
Mar-27-24Downgrade Guggenheim Buy → Neutral
Dec-05-23Upgrade Citigroup Neutral → Buy $7 → $10
Nov-20-23Initiated Citigroup Neutral $7
Sep-22-23Downgrade Wells Fargo Overweight → Equal Weight $24 → $8
Jun-13-25 02:02PM
Jun-12-25 05:00PM
Jun-11-25 07:01AM
Jun-10-25 07:00AM
Jun-03-25 04:30PM
04:00AM Loading…
May-23-25 04:00AM
May-15-25 04:05PM
May-13-25 04:05PM
May-12-25 05:00PM
May-07-25 04:30PM
May-01-25 11:07PM
06:30PM
05:15PM
04:01PM
Apr-29-25 07:01AM
02:00AM Loading…
02:00AM
Apr-28-25 10:00AM
Apr-24-25 04:30PM
Apr-12-25 10:20AM
Apr-11-25 05:00PM
Apr-07-25 03:27AM
Mar-31-25 04:30PM
Mar-30-25 03:50AM
02:50AM
Mar-26-25 09:39PM
07:00AM
Mar-17-25 07:01AM
Mar-12-25 05:30PM
Feb-24-25 04:30PM
Feb-23-25 03:03PM
09:20AM Loading…
Feb-22-25 09:20AM
Feb-20-25 04:01PM
09:06AM
Feb-14-25 02:06PM
Feb-13-25 04:30PM
10:31AM
Feb-12-25 05:30PM
Feb-11-25 07:01AM
Jan-13-25 07:00AM
Jan-06-25 04:30PM
Dec-03-24 05:51AM
Nov-25-24 04:30PM
Nov-13-24 05:00PM
Nov-12-24 04:05PM
Nov-07-24 09:05PM
04:01PM
07:00AM
Nov-04-24 04:30PM
Nov-01-24 03:05AM
Oct-31-24 07:00AM
Oct-30-24 09:13AM
Oct-28-24 08:35AM
Oct-26-24 07:01AM
Oct-21-24 04:30PM
Oct-17-24 07:01AM
02:30AM
Oct-14-24 04:30PM
Oct-09-24 03:50PM
08:02AM
Sep-26-24 04:01PM
Sep-12-24 05:00PM
Sep-10-24 04:01PM
Sep-06-24 09:20AM
Sep-05-24 05:34PM
Aug-22-24 04:30PM
Aug-06-24 04:30PM
Aug-01-24 04:01PM
Jul-25-24 04:30PM
Jul-10-24 08:43AM
Jul-08-24 04:30PM
Jun-24-24 07:32AM
Jun-11-24 05:00PM
May-15-24 05:00PM
May-09-24 04:30PM
May-08-24 04:30PM
01:22PM
May-07-24 11:29AM
03:07AM
May-06-24 08:59PM
05:30PM
05:10PM
04:01PM
Apr-29-24 04:30PM
Apr-24-24 07:05AM
03:00AM
Apr-04-24 04:30PM
Apr-03-24 04:30PM
Mar-13-24 05:00PM
Mar-11-24 07:05AM
Feb-26-24 04:30PM
Feb-23-24 07:05AM
02:00AM
Feb-16-24 09:52AM
Feb-15-24 04:01PM
Feb-08-24 04:30PM
Feb-01-24 04:30PM
Jan-25-24 04:05PM
Jan-08-24 07:00AM
Jan-02-24 04:30PM
Dec-14-23 07:30AM
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cline Christopher R.CHIEF FINANCIAL OFFICERMay 05 '25Sale21.051,78437,55393,126May 05 09:54 PM
Dube Eric MCHIEF EXECUTIVE OFFICERMay 05 '25Sale21.0518,924398,350419,173May 05 09:53 PM
Heerma PeterCHIEF COMMERCIAL OFFICERMay 05 '25Sale21.051,77137,280128,215May 05 09:53 PM
ROTE WILLIAM E.Chief Research OfficerMay 05 '25Sale21.053,19867,318100,241May 05 09:52 PM
REED ELIZABETH EChief Legal Officer and GCMay 05 '25Sale21.054,920103,56689,482May 05 09:51 PM
Christopher ClineOfficerMay 05 '25Proposed Sale21.051,78437,553May 05 07:45 PM
Peter HeermaOfficerMay 05 '25Proposed Sale21.051,77137,280May 05 07:41 PM
REED ELIZABETH EOfficerMay 05 '25Proposed Sale21.054,920103,566May 05 11:32 AM
Dube Eric MOfficerMay 05 '25Proposed Sale21.0518,924398,350May 05 11:20 AM
ROTE WILLIAM E.OfficerMay 05 '25Proposed Sale21.053,19867,318May 05 10:08 AM
Cline Christopher R.CHIEF FINANCIAL OFFICERApr 11 '25Sale13.144863189,990Apr 14 06:23 PM
Christopher ClineOfficerApr 11 '25Proposed Sale13.1448631Apr 11 07:03 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DFeb 12 '25Sale23.535,200122,35698,519Feb 12 09:30 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYFeb 12 '25Sale23.538,000188,24089,482Feb 12 09:28 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 11 '25Option Exercise16.6345,000748,20078,654Feb 12 09:27 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 11 '25Sale25.0054,2441,356,10054,410Feb 12 09:27 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 11 '25Sale25.003,07476,850127,634Feb 12 09:25 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 12 '25Sale23.532,56860,426125,066Feb 12 09:25 PM
Dube Eric MCHIEF EXECUTIVE OFFICERFeb 11 '25Sale24.0411,375273,455419,173Feb 12 09:23 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 12 '25Sale23.532,56860,42689,602Feb 12 09:22 PM
Peter HeermaOfficerFeb 12 '25Proposed Sale23.532,56860,426Feb 12 07:47 PM
Jula InrigOfficerFeb 12 '25Proposed Sale23.532,56860,426Feb 12 07:46 PM
ROTE WILLIAM E.OfficerFeb 12 '25Proposed Sale23.535,200122,356Feb 12 11:03 AM
REED ELIZABETH EOfficerFeb 12 '25Proposed Sale23.538,000188,240Feb 12 09:52 AM
SANDRA CALVINOfficerFeb 11 '25Proposed Sale25.0054,2441,356,100Feb 11 04:08 PM
PETER HEERMAOfficerFeb 11 '25Proposed Sale25.003,07476,850Feb 11 04:04 PM
Dube Eric MOfficerFeb 11 '25Proposed Sale24.0411,375273,455Feb 11 11:56 AM
Baynes Roy D.DirectorFeb 06 '25Option Exercise17.4410,000174,40041,000Feb 10 06:04 PM
Baynes Roy D.DirectorFeb 06 '25Sale22.0010,000220,00031,000Feb 10 06:04 PM
ROY D BAYNESDirectorFeb 06 '25Proposed Sale22.0010,000220,000Feb 06 04:21 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DFeb 03 '25Sale19.788,951177,05195,719Feb 04 08:30 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYFeb 03 '25Sale19.788,951177,05189,482Feb 04 08:30 PM
Dube Eric MCHIEF EXECUTIVE OFFICERFeb 03 '25Sale20.2150,6911,024,343430,548Feb 04 08:30 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 03 '25Sale20.124,20784,64585,236Feb 04 08:30 PM
Inrig JulaCHIEF MEDICAL OFFICERFeb 04 '25Sale20.111,06621,43784,170Feb 04 08:30 PM
Heerma PeterCHIEF COMMERCIAL OFFICERFeb 03 '25Sale20.125,166103,940122,708Feb 04 08:30 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERFeb 03 '25Sale20.125,192104,46390,038Feb 04 08:30 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 03 '25Sale20.123,34867,36263,654Feb 04 08:30 PM
JULA INRIGOfficerFeb 04 '25Proposed Sale20.111,06621,437Feb 04 04:11 PM
Peter HeermaOfficerFeb 03 '25Proposed Sale20.125,166103,934Feb 03 08:47 PM
Christopher ClineOfficerFeb 03 '25Proposed Sale20.125,192104,457Feb 03 08:46 PM
Sandra CalvinOfficerFeb 03 '25Proposed Sale20.123,34867,358Feb 03 08:41 PM
Jula InrigOfficerFeb 03 '25Proposed Sale20.124,20784,640Feb 03 08:40 PM
REED ELIZABETH EOfficerFeb 03 '25Proposed Sale19.788,951177,051Feb 03 12:26 PM
Dube Eric MOfficerFeb 03 '25Proposed Sale19.7850,6911,002,668Feb 03 11:22 AM
ROTE WILLIAM E.OfficerFeb 03 '25Proposed Sale19.788,951177,051Feb 03 11:11 AM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DJan 22 '25Sale19.462,43747,42483,170Jan 23 08:40 PM
Dube Eric MCHIEF EXECUTIVE OFFICERJan 22 '25Sale19.4610,736208,923351,239Jan 23 08:39 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYJan 22 '25Sale19.462,43747,42476,933Jan 23 08:37 PM
Baynes Roy D.DirectorJan 23 '25Option Exercise17.5016,000280,00047,000Jan 23 08:36 PM
Baynes Roy D.DirectorJan 23 '25Sale20.0016,000320,00031,000Jan 23 08:36 PM
Heerma PeterCHIEF COMMERCIAL OFFICERJan 22 '25Sale18.941,58430,002106,374Jan 23 08:35 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERJan 22 '25Sale18.9486516,38473,730Jan 23 08:33 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERJan 22 '25Sale18.9492517,52054,002Jan 23 08:31 PM
ROY D BAYNESDirectorJan 23 '25Proposed Sale20.0016,000320,000Jan 23 04:14 PM
Dube Eric MOfficerJan 22 '25Proposed Sale19.4610,736208,923Jan 22 10:34 AM
REED ELIZABETH EOfficerJan 22 '25Proposed Sale19.462,43747,424Jan 22 10:18 AM
ROTE WILLIAM E.OfficerJan 22 '25Proposed Sale19.462,43747,424Jan 22 09:36 AM
Inrig JulaCHIEF MEDICAL OFFICERJan 03 '25Sale19.102,06639,46159,883Jan 06 07:21 PM
Inrig JulaCHIEF MEDICAL OFFICERJan 06 '25Sale18.764408,25459,443Jan 06 07:21 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERDec 26 '24Option Exercise12.6715,000190,05069,927Dec 27 07:47 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERDec 26 '24Sale17.2215,000258,27754,927Dec 27 07:47 PM
SANDRA CALVINOfficerDec 26 '24Proposed Sale17.2215,000258,278Dec 26 04:13 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERNov 25 '24Option Exercise12.6715,000190,05067,017Nov 25 09:00 PM
Calvin SandraSVP, CHIEF ACCOUNTING OFFICERNov 25 '24Sale18.3012,090221,25854,927Nov 25 09:00 PM
Calvin SandraOfficerNov 25 '24Proposed Sale18.3012,090221,258Nov 25 05:59 PM
LYONS GARY ADirectorOct 04 '24Option Exercise10.4840,000419,20091,000Oct 04 07:15 PM
LYONS GARY ADirectorOct 04 '24Sale14.7340,000589,10151,000Oct 04 07:15 PM
GARY A LYONSOfficerOct 04 '24Proposed Sale13.6540,000546,000Oct 04 04:21 PM
Meckler Jeffrey ADirectorSep 30 '24Option Exercise10.4840,000419,200121,000Sep 30 08:38 PM
Meckler Jeffrey ADirectorSep 30 '24Sale14.0640,000562,32481,000Sep 30 08:38 PM
JEFFREY MECKLERDirectorSep 30 '24Proposed Sale14.0640,000562,324Sep 30 04:22 PM
Calvin SandraOfficerSep 11 '24Proposed Sale14.8015,000222,000Sep 11 06:29 PM
Inrig JulaCHIEF MEDICAL OFFICERSep 10 '24Sale12.986848,87861,949Sep 10 04:05 PM
ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DSep 09 '24Sale11.524,38750,53884,455Sep 09 09:20 PM
REED ELIZABETH ESVP, GC & CORPORATE SECRETARYSep 09 '24Sale11.524,38750,53878,633Sep 09 09:20 PM
Dube Eric MCHIEF EXECUTIVE OFFICERSep 09 '24Sale11.5221,125243,360361,975Sep 09 09:20 PM
Inrig JulaCHIEF MEDICAL OFFICERSep 09 '24Sale11.522,19125,24062,633Sep 09 09:20 PM
Heerma PeterCHIEF COMMERCIAL OFFICERSep 09 '24Sale11.522,19125,240107,958Sep 09 09:20 PM
Cline Christopher R.CHIEF FINANCIAL OFFICERSep 09 '24Sale11.522,49028,68574,595Sep 09 09:20 PM
REED ELIZABETH EOfficerSep 09 '24Proposed Sale11.524,38750,538Sep 09 10:54 AM
ROTE WILLIAM E.OfficerSep 09 '24Proposed Sale11.524,38750,538Sep 09 10:35 AM
Dube Eric MOfficerSep 09 '24Proposed Sale11.5221,125243,360Sep 09 10:34 AM
Cline Christopher R.CHIEF FINANCIAL OFFICERSep 04 '24Sale9.515144,88870,335Sep 05 09:30 PM
NBIX Neurocrine Biosciences, Inc daily Stock Chart
Index- P/E42.91 EPS (ttm)2.95 Insider Own3.53% Shs Outstand99.00M Perf Week1.23%
Market Cap12.52B Forward P/E21.25 EPS next Y5.96 Insider Trans-8.20% Shs Float95.47M Perf Month2.92%
Income305.80M PEG1.23 EPS next Q0.98 Inst Own94.26% Short Float4.26% Perf Quarter14.97%
Sales2.41B P/S5.19 EPS this Y21.64% Inst Trans0.17% Short Ratio2.82 Perf Half Y-4.89%
Book/sh25.61 P/B4.94 EPS next Y48.80% ROA8.54% Short Interest4.06M Perf Year-6.46%
Cash/sh9.53 P/C13.27 EPS next 5Y34.79% ROE12.43% 52W Range84.23 - 157.98 Perf YTD-7.29%
Dividend Est.- P/FCF25.45 EPS past 5Y53.47% ROIC10.25% 52W High-19.89% Beta0.24
Dividend TTM- Quick Ratio3.02 Sales past 5Y24.48% Gross Margin97.77% 52W Low50.24% ATR (14)2.97
Dividend Ex-DateDec 29, 1995 Current Ratio3.13 EPS Y/Y TTM-19.24% Oper. Margin20.78% RSI (14)64.01 Volatility1.09% 0.86%
Employees1800 Debt/Eq0.19 Sales Y/Y TTM21.73% Profit Margin12.68% Recom1.37 Target Price160.00
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q-81.59% Payout0.00% Rel Volume1.08 Prev Close127.31
Sales Surprise2.32% EPS Surprise-85.05% Sales Q/Q11.12% EarningsMay 05 AMC Avg Volume1.44M Price126.55
SMA201.91% SMA509.93% SMA2004.33% Trades Volume1,560,816 Change-0.60%
Date Action Analyst Rating Change Price Target Change
Apr-15-25Upgrade Needham Hold → Buy $138
Apr-14-25Upgrade RBC Capital Mkts Sector Perform → Outperform $137
Feb-11-25Initiated Deutsche Bank Hold $138
Oct-10-24Resumed Raymond James Outperform $155
Aug-29-24Upgrade Piper Sandler Neutral → Overweight $131 → $159
Apr-24-24Upgrade Wells Fargo Equal Weight → Overweight $140 → $170
Dec-13-23Resumed Citigroup Neutral $127
Dec-12-23Initiated Deutsche Bank Buy $136
Oct-24-23Resumed Cantor Fitzgerald Overweight $135 → $140
Aug-21-23Reiterated Mizuho Neutral $112 → $113
Today 08:30AM
Jun-17-25 06:20AM
Jun-12-25 06:20AM
Jun-09-25 04:05PM
Jun-03-25 11:40AM
08:30AM Loading…
Jun-02-25 08:30AM
May-30-25 04:30PM
May-29-25 12:03AM
May-28-25 04:05PM
May-27-25 06:20AM
May-26-25 06:20AM
May-20-25 06:20AM
May-16-25 08:30AM
08:25AM
May-15-25 04:05PM
11:40AM Loading…
11:40AM
May-14-25 04:05PM
May-13-25 03:48PM
12:07PM
06:20AM
May-08-25 08:30AM
May-07-25 03:34AM
May-06-25 04:40PM
04:01PM
08:36AM
08:30AM
06:20AM
03:05AM
May-05-25 08:33PM
05:30PM
05:10PM Loading…
05:10PM
04:09PM
04:01PM
08:30AM
May-01-25 07:18AM
Apr-30-25 11:43AM
08:00AM
Apr-29-25 10:01AM
Apr-28-25 10:00AM
Apr-24-25 04:05PM
Apr-22-25 06:05PM
Apr-16-25 05:51PM
Apr-14-25 04:01PM
Apr-07-25 11:39AM
Apr-04-25 08:00AM
Mar-31-25 04:03PM
08:30AM
Mar-28-25 03:59PM
Mar-27-25 07:30AM
Mar-26-25 07:00PM
Mar-25-25 06:20AM
Mar-20-25 01:45PM
09:05AM
08:30AM
Mar-18-25 05:15AM
Mar-17-25 08:30AM
Mar-14-25 05:30AM
Mar-11-25 04:01PM
Mar-06-25 07:26AM
Mar-05-25 08:30AM
Feb-27-25 04:05PM
Feb-25-25 04:01PM
Feb-21-25 03:11PM
08:00AM
Feb-18-25 04:08PM
Feb-10-25 06:18PM
08:32AM
Feb-08-25 11:01AM
Feb-07-25 04:43PM
04:25PM
03:15PM
01:05PM
08:15AM
02:23AM
Feb-06-25 05:15PM
04:27PM
04:01PM
Feb-04-25 12:47PM
09:15AM
Jan-30-25 04:01PM
Jan-29-25 10:01AM
Jan-28-25 10:24AM
08:30AM
Jan-27-25 04:05PM
Jan-23-25 04:05PM
Jan-21-25 04:05PM
Jan-08-25 08:30AM
08:30AM
Jan-06-25 04:01PM
Dec-24-24 03:23PM
Dec-20-24 08:00AM
Dec-16-24 04:10PM
09:10AM
Dec-13-24 07:00PM
06:55PM
Dec-02-24 01:55PM
Nov-30-24 04:31PM
Nov-26-24 04:01PM
Nov-07-24 08:30AM
Nov-05-24 04:01PM
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GORMAN KEVIN CHARLESDirectorMay 27 '25Sale120.389,6131,157,211514,596May 29 06:15 PM
KEVIN CHARLES GORMANDirectorMay 27 '25Proposed Sale120.189,6131,155,290May 27 04:38 PM
RASTETTER WILLIAM HDirectorMay 22 '25Option Exercise0.002,869040,360May 22 06:15 PM
POON CHRISTINE ADirectorMay 22 '25Option Exercise0.001,43501,435May 22 05:32 PM
Sharp ShaliniDirectorMay 22 '25Option Exercise0.001,43502,429May 22 05:28 PM
SHERWIN STEPHEN ADirectorMay 22 '25Option Exercise0.002,869013,542May 22 05:26 PM
POPS RICHARD FDirectorMay 22 '25Option Exercise0.002,869034,480May 22 05:23 PM
MORROW GEORGE JDirectorMay 22 '25Option Exercise0.002,86907,068May 22 05:20 PM
LYONS GARY ADirectorMay 22 '25Option Exercise0.001,4350120,482May 22 05:18 PM
Norwalk Leslie VDirectorMay 22 '25Option Exercise0.001,43502,429May 22 05:14 PM
Mercier JohannaDirectorMay 22 '25Option Exercise0.001,43503,535May 22 05:12 PM
Cooke JulieChief Human Resources OfficerMay 16 '25Option Exercise61.826,468399,85226,858May 20 04:43 PM
RASTETTER WILLIAM HDirectorMay 05 '25Option Exercise42.7630,0001,282,80067,491May 07 07:05 PM
RASTETTER WILLIAM HDirectorMay 05 '25Sale110.2030,0003,305,95237,491May 07 07:05 PM
WILLIAM H. RASTETTEROfficerMay 05 '25Proposed Sale109.6830,0003,290,400May 05 04:40 PM
Cooke JulieChief Human Resources OfficerFeb 13 '25Option Exercise0.002,910020,945Feb 14 07:13 PM
Cooke JulieChief Human Resources OfficerFeb 13 '25Sale116.781,551181,12919,544Feb 14 07:13 PM
GORMAN KEVIN CHARLESDirectorFeb 13 '25Option Exercise0.0010,9790527,221Feb 14 06:57 PM
GORMAN KEVIN CHARLESDirectorFeb 13 '25Sale116.695,844681,914521,618Feb 14 06:57 PM
SHERWIN STEPHEN ADirectorFeb 13 '25Sale116.6913,8311,613,92310,673Feb 14 06:49 PM
ROBERTS EIRYChief Medical OfficerFeb 13 '25Option Exercise0.004,605036,140Feb 14 06:42 PM
ROBERTS EIRYChief Medical OfficerFeb 13 '25Sale116.851,718200,74234,252Feb 14 06:42 PM
ROBERTS EIRYChief Medical OfficerFeb 14 '25Sale115.0450057,52135,640Feb 14 06:42 PM
Onyia JudeChief Scientific OfficerFeb 13 '25Option Exercise0.005,407019,536Feb 14 06:35 PM
Onyia JudeChief Scientific OfficerFeb 13 '25Sale116.792,879336,23916,846Feb 14 06:35 PM
Lippoldt DarinChief Legal OfficerFeb 13 '25Option Exercise0.004,100044,491Feb 14 06:26 PM
Lippoldt DarinChief Legal OfficerFeb 13 '25Sale116.752,184254,99242,474Feb 14 06:26 PM
Gano KyleChief Executive OfficerFeb 13 '25Option Exercise0.004,8070141,113Feb 14 06:20 PM
Gano KyleChief Executive OfficerFeb 13 '25Sale116.852,558298,908138,872Feb 14 06:20 PM
Delaet IngridChief Regulatory OfficerFeb 13 '25Option Exercise0.002,75905,485Feb 14 06:13 PM
Delaet IngridChief Regulatory OfficerFeb 13 '25Sale116.711,471171,6744,084Feb 14 06:13 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 13 '25Option Exercise0.003,35204,395Feb 14 06:08 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 13 '25Sale116.741,785208,3872,854Feb 14 06:08 PM
BENEVICH ERICChief Commercial OfficerFeb 13 '25Option Exercise0.004,044045,745Feb 14 06:03 PM
BENEVICH ERICChief Commercial OfficerFeb 13 '25Sale116.732,154251,42843,784Feb 14 06:03 PM
ABERNETHY MATTChief Financial OfficerFeb 13 '25Option Exercise0.004,807037,016Feb 14 06:00 PM
ABERNETHY MATTChief Financial OfficerFeb 13 '25Sale116.862,558298,92334,775Feb 14 06:00 PM
EIRY WYN ROBERTSOfficerFeb 14 '25Proposed Sale115.0450057,521Feb 14 04:12 PM
STEPHEN A SHERWINDirectorFeb 13 '25Proposed Sale117.1813,8311,620,717Feb 13 04:38 PM
MATTHEW ABERNETHYOfficerFeb 13 '25Proposed Sale117.181,352158,427Feb 13 04:38 PM
MATTHEW C ABERNETHYOfficerFeb 13 '25Proposed Sale117.181,206141,319Feb 13 04:37 PM
KEVIN CHARLES GORMANDirectorFeb 13 '25Proposed Sale117.183,012352,946Feb 13 04:37 PM
KYLE W GANOOfficerFeb 13 '25Proposed Sale117.181,206141,319Feb 13 04:37 PM
JULIE SMITH COOKEOfficerFeb 13 '25Proposed Sale117.1875588,471Feb 13 04:37 PM
ERIC S BENEVICHOfficerFeb 13 '25Proposed Sale117.181,056123,742Feb 13 04:36 PM
JUDE ONYIAOfficerFeb 13 '25Proposed Sale117.181,447169,559Feb 13 04:36 PM
INGRID DELAETOfficerFeb 13 '25Proposed Sale117.1875588,471Feb 13 04:36 PM
DAVID WARREN BOYEROfficerFeb 13 '25Proposed Sale117.1883097,259Feb 13 04:35 PM
DARIN LIPPOLDTOfficerFeb 13 '25Proposed Sale117.181,086127,257Feb 13 04:35 PM
EIRY WYN ROBERTSOfficerFeb 13 '25Proposed Sale117.1860470,777Feb 13 04:35 PM
EIRY ROBERTSOfficerFeb 13 '25Proposed Sale117.181,114130,539Feb 13 04:34 PM
DARIN LIPPOLDTOfficerFeb 13 '25Proposed Sale117.181,098128,664Feb 13 04:34 PM
ERIC BENEVICHOfficerFeb 13 '25Proposed Sale117.181,098128,664Feb 13 04:34 PM
JUDE ONYIAOfficerFeb 13 '25Proposed Sale117.181,432167,802Feb 13 04:34 PM
INGRID DELAETOfficerFeb 13 '25Proposed Sale117.1871683,901Feb 13 04:33 PM
DAVID WARREN BOYEROfficerFeb 13 '25Proposed Sale117.18955111,907Feb 13 04:33 PM
JULIE COOKEOfficerFeb 13 '25Proposed Sale117.1879693,275Feb 13 04:33 PM
KYLE GANOOfficerFeb 13 '25Proposed Sale117.181,352158,427Feb 13 04:32 PM
Kevin Charles GormanDirectorFeb 13 '25Proposed Sale117.182,832331,854Feb 13 04:31 PM
Cooke JulieChief Human Resources OfficerFeb 08 '25Option Exercise0.001,329019,531Feb 12 07:00 PM
Cooke JulieChief Human Resources OfficerFeb 10 '25Sale118.2870082,79218,831Feb 12 07:00 PM
GORMAN KEVIN CHARLESDirectorFeb 08 '25Option Exercise0.004,3180521,348Feb 12 06:56 PM
GORMAN KEVIN CHARLESDirectorFeb 10 '25Sale118.372,274269,167519,074Feb 12 06:56 PM
ROBERTS EIRYChief Medical OfficerFeb 08 '25Option Exercise0.001,860034,233Feb 12 06:52 PM
ROBERTS EIRYChief Medical OfficerFeb 10 '25Sale118.22980115,85333,253Feb 12 06:52 PM
Lippoldt DarinChief Legal OfficerFeb 08 '25Option Exercise0.001,727042,590Feb 12 06:49 PM
Lippoldt DarinChief Legal OfficerFeb 10 '25Sale118.25911107,72741,679Feb 12 06:49 PM
Gano KyleChief Executive OfficerFeb 08 '25Option Exercise0.001,8600138,638Feb 12 06:48 PM
Gano KyleChief Executive OfficerFeb 10 '25Sale118.39980116,020137,658Feb 12 06:48 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 08 '25Option Exercise0.001,32902,698Feb 12 06:46 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 10 '25Sale118.3170082,8201,998Feb 12 06:46 PM
BENEVICH ERICChief Commercial OfficerFeb 08 '25Option Exercise0.001,860043,779Feb 12 06:44 PM
BENEVICH ERICChief Commercial OfficerFeb 10 '25Sale118.31980115,94042,799Feb 12 06:44 PM
ABERNETHY MATTChief Financial OfficerFeb 08 '25Option Exercise0.001,860034,541Feb 12 06:41 PM
ABERNETHY MATTChief Financial OfficerFeb 10 '25Sale118.27980115,90933,561Feb 12 06:41 PM
KYLE W GANOOfficerFeb 10 '25Proposed Sale122.62980120,168Feb 10 04:33 PM
JULIE SMITH COOKEOfficerFeb 10 '25Proposed Sale122.6270085,834Feb 10 04:33 PM
DAVID WARREN BOYEROfficerFeb 10 '25Proposed Sale122.6270085,834Feb 10 04:33 PM
ERIC BENEVICHOfficerFeb 10 '25Proposed Sale122.62980120,168Feb 10 04:32 PM
KEVIN CHARLES GORMANDirectorFeb 10 '25Proposed Sale122.622,274278,838Feb 10 04:32 PM
DARIN LIPPOLDTOfficerFeb 10 '25Proposed Sale122.62911111,707Feb 10 04:32 PM
EIRY WYN ROBERTSOfficerFeb 10 '25Proposed Sale122.62980120,168Feb 10 04:31 PM
MATTHEW C ABERNETHYOfficerFeb 10 '25Proposed Sale122.62980120,168Feb 10 04:30 PM
Cooke JulieChief Human Resources OfficerJan 31 '25Option Exercise0.001,740019,942Feb 04 06:05 PM
Cooke JulieChief Human Resources OfficerJan 31 '25Sale152.891,740266,02518,202Feb 04 06:05 PM
GORMAN KEVIN CHARLESDirectorJan 31 '25Option Exercise0.005,1410519,737Feb 04 05:58 PM
GORMAN KEVIN CHARLESDirectorJan 31 '25Sale152.922,707413,967517,030Feb 04 05:58 PM
ROBERTS EIRYChief Medical OfficerJan 31 '25Option Exercise0.002,769033,830Feb 04 05:54 PM
ROBERTS EIRYChief Medical OfficerJan 31 '25Sale152.801,457222,63632,373Feb 04 05:54 PM
Onyia JudeChief Scientific OfficerJan 31 '25Option Exercise0.00238015,687Feb 04 05:51 PM
Onyia JudeChief Scientific OfficerJan 31 '25Sale152.9712619,27415,561Feb 04 05:51 PM
Lippoldt DarinChief Legal OfficerJan 31 '25Option Exercise0.002,373042,113Feb 04 05:49 PM
Lippoldt DarinChief Legal OfficerJan 31 '25Sale152.911,250191,13340,863Feb 04 05:49 PM
Gano KyleChief Executive OfficerJan 31 '25Option Exercise0.002,9270138,319Feb 04 05:47 PM
Gano KyleChief Executive OfficerJan 31 '25Sale152.871,541235,577136,778Feb 04 05:47 PM
Delaet IngridChief Regulatory OfficerJan 31 '25Option Exercise0.0080103,308Feb 04 05:45 PM
Delaet IngridChief Regulatory OfficerFeb 03 '25Option Exercise0.001,17904,065Feb 04 05:45 PM
Delaet IngridChief Regulatory OfficerFeb 03 '25Sale149.2962393,0083,442Feb 04 05:45 PM
Delaet IngridChief Regulatory OfficerJan 31 '25Sale153.0542264,5872,886Feb 04 05:45 PM
Boyer David W.Chief Corp. Affairs OfficerJan 31 '25Option Exercise0.002,09602,473Feb 04 05:42 PM